Background: Diarrhea can be caused by pathogenic microorganisms and chemicals.
| INTRODUC TI ON
Diarrhea is defined as an excessive fluid loss of 200 g (200 mL) per day. 1 Diarrhea diseases cause several million deaths in the world annually, and diarrhea is the most common cause of morbidity and mortality globally, affecting many infants in the developing countries. [2] [3] [4] Overcrowding, poor sanitary conditions, contaminated water, inadequate food hygiene and poor nutrition predispose mainly children to the risk of diarrhea diseases. 5, 6 Ingested food components or medicines such as artificial sweeteners and lactose may also result in diarrhea. 7 Evaluating the risk of diarrhea diseases requires knowledge of the complex interaction between biological, socio-economic, behavioral, and environmental factors. 8 In Nigeria, for example, the Nigeria Demographic and Health Survey reported that diarrhea prevalence is highest in the northeast (22%) and lowest in the southwest (7%). 9 Diarrhea induces dehydration and electrolyte imbalance, especially in children, infants and frail elderly patients. 10 Acute watery diarrhea usually lasts for less than 7 days, although it can last for up to 14 days. 11 Diarrhea is also caused by a wide range of bacteria such as Campylobacter jejuni, Escherichia coli, Salmonella species and Aeromonas species. 12 Loss of large quantities of intestinal electrolytes and fluid secretion occurs in patients with cholera caused by Vibrio cholera. Cholera toxin activates adenylate cyclase by causing ADP-ribosylation of the G-proteins, resulting in constitutive stimulation of the cyclase. 13 Elevated cAMP levels in turn activate protein kinase A and protein phosphorylation opens the luminal Cl-channel in secretory cells and inhibits Na + /H + exchange in absorptive cells. The net result is gross NaCl secretion. Management of diarrhea involves the use of rehydration therapy, nutritional supplements, drugs 14 and plant extracts. 15 Medicinal plants are the primary source of medication used as complementary or alternative treatments to orthodox medicine. 16 Byrsocarpus coccineus Schum and Thonn is a climbing shrub found in west and central African countries including Nigeria, Ghana, Cameroun, Ivory Coast, Togo, Central African and Congo. It is known as Onyakpechi in Igala, Tsamiyar kasa in Hausa, Oke abolo and Mybo-apapea in Yoruba and Onyakwachi in Idoma. 17 It is used in traditional African medicine for the treatment of earache, gonorrhea, impotence, jaundice, piles, diarrhea, tumour and wounds, 18 and has been shown to have anxiolytic, sedative, 19 anti-inflammatory, 20 analgesic, 21 antidiarrhea, 22 antimicrobial 23 and uterotonic activities. 24 Radostits et al have reported that colibacillosis is the major cause of death in neonatal animals, because maternal immunoglobins are not transferred transplacentally. 25 In addition, whereas castor oil obtained from Ricinus communis is used in the treatment of constipation, sometimes the oil causes diarrhea in both human and animals. Since a number of plants can be used to treat diarrhea induced by bacteria or toxicants, [26] [27] [28] [29] [30] we investigated the effects of a root bark extract of B. coccineus on chemically and bacterially induced diarrhea. 
| MATERIAL S AND ME THODS

| Sample collection and identification
| Extraction of B. coccineus root bark
About 1.5 kg of B. coccineus root was obtained, washed with distilled water and subsequently air dried in the laboratory at room temperature. The dry root bark was pulverized into fine powder using a grinder and kept in a cellophane bag at 4°C until use. Fifty grams (50 g) of B. coccineus root powder was placed in a conical flask containing 100 mL of distilled water. The mixture was thoroughly shaken intermittently throughout the period of extraction using a stirrer, allowed to stand overnight, filtered with Whatman No.1 filter paper into a measuring cylinder, concentrated at 60°C in an incubator and stored in a refrigerator at 4°C until required. 21 
| Qualitative phytochemical analysis
The aqueous extract of Brysocarpus coccineus root bark was qualitatively evaluated for the presence of alkaloids, cardiac glycosides, saponins, tannins, steroids, flavonoids, anthraquinones, total glycosides, and reducing sugars using the methods of Trease and Evans, 31 Harborne 32 and Edeoga et al. 33 
| Quantitative phytochemical analysis
The root bark powder of Byrsocarpus coccineus was quantitatively analyzed for the presence of alkaloid, flavonoid, phenol, saponin and tannin according to the methods described by Ordonez et al, 34 Van Burden and Robinson 35 and Skerget et al. 36 
| Experimental animals
A total of one hundred and ten (110) adult Wistar albino rats of both sexes (55 males; 55 females), weighing 218 ± 28.6 g were used for the study. The animals were obtained from the National Veterinary Research Institute, Vom, Plateau State, Nigeria and were kept under standard housing conditions and allowed to acclimatize for 2 weeks before commencement of the study. They were fed with a commercial rat feed, Finisher ® produced by Grand Cereals and Oil Mills Ltd. Clean water was provided ad libitium.
The research was carried out according to protocols and procedures approved by the Department of Veterinary Biochemistry,
Physiology and Pharmacology Ethical Committee, Federal
University of Agriculture Makurdi, Nigeria.
| Acute oral toxicity study
The up and down procedure revised by Saganuwan 37 was adopted for determination of median lethal dose (LD 50 ) using five female rats. All rats were dosed at 5000 mg/kg body weight and observed for 48 hours in the following sequence. The first rat was dosed and observed for 48 hours. The second and third rats were then concurrently dosed and observed. The fourth and fifth rats were then sequentially dosed and observed. All the rats were observed for an additional 12 days for signs of delayed toxicity or death.
| Effects of B. coccineus extract on castor oilinduced diarrhea in rats
Twenty-five female rats were used for this study. The method of Offiah and Chikwendu 38 was adopted. The rats were starved overnight prior to the study, but allowed access to water. They were separated into five groups of five. The rats in groups I--III were respectively orally administered 50, 100 and 200 mg/kg body weight of the extract, while the rats in group IV were administered 2 mL of normal saline. The group V rats were administered the antidiarrheal diphenoxylate hydrochloride (5 mg/kg) by intraperitoneal route. All the rats were housed singly in separate cages lined with white blotting paper. One hour after treatment, each of the rats was treated with 1 mL of castor oil, orally. The rats were then observed for 6 hours for watery faeces. All the observations were recorded as percentage (%) protection.
| Effects of B. coccineus extract on gastrointestinal motility
The method of Chime et al 39 was used to test the effect of the extract on gastrointestinal motility. Twenty-five female rats were fasted overnight, with access to water. They were then divided into five groups of five. The rats in group I were orally administered 2 mL normal saline (0.9%), those in group II were administered 3 mg/kg of the antidiarrheal atropine intraperitoneally, and those in groups III--V were orally administered 50, 100, and 200 mg/kg of the extract, respectively. One millilitre (1 mL) of castor oil was administered to each animal, before administration of the drug and the extract. Thirty minutes after the drug and extract administration, 1 mL of 5% activated charcoal suspension in a 10% aqueous solution of acacia powder was administered, and the rats were sacrificed 30 minutes later. The abdomens were opened and the distances travelled by the charcoal meal were measured and expressed as a percentage of the total length of the intestine from pylorus to caecum. 40 
| Effects of B. coccineus extract on castor oilinduced enteropooling
The intraluminal fluid accumulation due to the effect of castor oil was determined by the method of Robert et al 41 Twenty-five male rats, separated into five groups of five, were used for this study. The rats were fasted overnight, before the commencement of the study.
Group I rats were orally administered 2 mL normal saline, group II rats were administered atropine (3 mg/kg) intraperitoneally, and rats in groups III--V were orally administered 50, 100 and 200 mg/kg of the extract, respectively. After 1 hour, castor oil was administered to each animal. The animals were sacrificed immediately and the small intestine removed, tied on both ends with thread and weighed. The intestinal content was collected by milking and the quantity measured. 
| Determination of antibacterial activity of B. coccineus extract
| Determination of in vitro antibacterial activity
The well diffusion method described by the National Committee 
| Minimal inhibitory concentration
The minimal inhibitory concentration of the extract was determined using the dilution method described by Greenwood. 43 Serial dilutions of the extract were carried out to obtain concentrations of 2.5, 1.25, 0.63, 0.31, 0.16, and 0.07 mg/mL. A drop of the test organism was added to each concentration and incubated at 37°C for 24 hours. Serial dilutions of the standard antibiotic (oxytetracycline) were made and tested for comparison.
| In vivo antibacterial activity of B. coccineus extract in Wistar albino rats infected
| Escherichia coli Preparation of E. coli inoculum
The pathogenic E. coli strain used for these tests was obtained from the Department of Veterinary Microbiology, Ahmadu Bello University, Zaria. The infective inoculum was prepared from an overnight nutrient broth culture of the isolate and the number of organisms estimated as colony forming units (CFU) per millitre of suspension in sterile nutrient broth, matched using a standard MacFarland scale. Colony count was performed on the diluted culture to achieve a titre of 3.0 × 10 6 CFU/mL. 44 All the rats were starved overnight, before the experimental infection. Each rat was inoculated orally with 0.5 mL of the inoculum. The uninfected control rats were inoculated with sterile broth.
Experimental groups and E. coli inoculation
Thirty male rats were randomly divided into six groups (I-VI) of five and kept in separate cages. Groups I, II and III were inoculated with E. coli and treated with the extract at doses of 50, 100 and 200 mg/kg, respectively. Group IV was inoculated with E. coli and treated with 5 mg/kg of 5% oxyteyracycline (positive control), and group V was inoculated but untreated (negative control).
Group VI served as the normal control group (not inoculated and non-treated). Oxytetracycline (5 mg/kg, manufactured by Hebe Yuanzheng Pharmaceutical Limited) was used as the standard antibiotic. Treatment with the extract and standard antibiotic commenced 3 days post infection and lasted for a period of 7 days.
| Clinical signs and treatments
Rats from all the groups were closely observed for clinical signs of infection. The morbidity and mortality in all the groups was recorded.
The body weights of the rats were recorded at days 3, 7, 12 and 18 post-infection.
| Hematology
Blood samples obtained through the media canthus of the eye were used for the determination of hematological parameters such as red blood cell (RBC) count, packed cell volume (PCV), hemoglobin concentration and white blood cell (WBC) count. 45 
| Histopathological examination
Two rats randomly selected from each group, making a total of 12, were sacrificed using phenobarbitone (37 mg/kg) on day 19 post infection. The liver, kidney and intestine were collected from the rats and fixed in Bouin's fluid for 24 hours. The tissues were dehydrated through graded concentrations of ethanol (70%, 95% and 100%), cleared in xylene and embedded in paraffin wax. The embedded tissues were sectioned at 7 μm thickness and stained with Hematoxylin and Eosin (H&E) for light microscopic examination. Photomicrographs of the sections were taken using a digital camera. 46 
| Statistical analysis
The results of the quantitative analysis of phytochemical contents are presented as percentiles. The frequencies of droppings, gastrointestinal transit time, enteropooling, antimicrobial zones of inhibition and average organ weight gain were calculated using one-way analysis of variance. The least significance difference was set at the 5% level. The minimum inhibitory concentration of the test microorganism, average weight gains of the infected rats, RBC, PCV and WBC counts, hemoglobin, total blood volume, red cell volume, and plasma volume were calculated using two-way analysis of variance. Fisher's test was used to detect significant differences, set at the 5% level. 47 
| RE SULTS
| Qualitative phytochemical analysis
Results of the qualitative phytochemical analysis of the aqueous root bark extract of B. coccineus revealed the presence of flavonoids, tannins, saponins, alkaloids and phenols. The analysis also revealed the absence of steroids, terpenoids, cardiac glycosides and anthroquinones (Table 1) .
TA B L E 1 The phytochemical constituents of an aqueous root bark extract of Byrsocarpus coccineus
Phytochemical constituents Results
Flavonoids + 
| Quantitative phytochemical analysis
This analysis showed the quantity of various constituents present in the aqueous root bark extract of B. coccineus. Saponins were present at the highest quantity (10.6%), followed by tannins (7.6%), flavonoids (6.2%), phenols (5.8%) and alkaloids (4.4%) ( Table 2 ).
| Acute oral toxicity study
Oral administration of the aqueous root bark extract of B. coccineus to rats produced no visible signs of toxicity at 5000 mg/kg body weight. Hence, the median lethal dose (LD 50 ) value for the extract was estimated to be above 5000 mg/kg. 
| Effects of B. coccineus extract on castor oilinduced diarrhea
| Effects of B. coccineus extract on gastrointestinal transit of charcoal
The effect of the extract on gastrointestinal transit of charcoal is shown in Table 4 . There was a significant (P < .05) decrease in the intestinal transit of charcoal in the extract-treated groups compared to the control group. The charcoal travelled very rapidly along the intestine in the control group, while the rate of movement was significantly (P < .05) reduced in the rats treated with the extract. The rats treated with 3 mg/kg of atropine had a slower rate of charcoal movement along the small intestine compared to the extract-treated rats ( Table 4 ). The transit of charcoal in the groups treated with the extract appeared to be statistically similar to the group treated with atropine.
| Effects of B. coccineus extract on castor oilinduced enteropooling
The effect of the extract on castor oil-induced enteropooling is shown in 
| In vivo antibacterial effects of B. coccineus extract on Wistar albino rats infected with E. coli
| Clinical signs
Rats from infected groups showed signs of depression and anorexia at There was a significant (P < .05) decrease in the body weights of the extract-treated groups compared to those of oxytetracyclinetreated and uninfected control groups. The body weights of the rats in the infected untreated group were the lowest among all the groups. 
| Effects of E. coli infection and the extract treatment on body weight gain of rats
| Effects of E. coli infection and the extract treatment on hematological parameters of rats
The Infection of rats with E. coli resulted in a decreased packed cell volume ( Table 11) 
TA B L E 1 2 Effects of the aqueous root bark extract of Byrsocarpus coccineus on white blood cells (WBC) of rats infected with E. coli
and the values appear to be similar to that of the uninfected control group (Table 13 ). There were significant (P < .05) increases in neutrophil counts in all the infected groups treated with the extract on day 3 post infection. Treatment with the extract decreased the neutrophil values below that of the group infected and treated with oxytetracycline and the group infected but not treated, on day 7 post infections. All the infected groups had significantly (P < .05) increased neutrophil counts on day 18 compared to the uninfected control group. Basophils, eosinophils and monocytes were increased significantly (P < .05) at various doses on days 3, 7 and 18 post-infection (Table 13 ).
| Histopathological changes
A photomicrograph of the normal liver of a Wistar albino rat (uninfected and untreated) showed a normal portal triad (arrow) and hepatocytes (H) ( Figure 1A ). However, a photomicrograph of the liver of a Wistar albino rat infected with E. coli but neither treated with extract nor the antibiotic showing marked cellular infiltration around the portal triad (F) and between the hepatocytes (arrow) ( Figure 1B) . The photomicrograph of the liver of a Wistar albino rat infected with E. coli and treated with 200 mg/kg of the aqueous root bark extract of B. coccineus showed a normal central vein (V) and hepatocytes (H) ( Figure 1C ). In the intestine, there was severe villous collapse, with matting and fusion of the villi (Figure 2A) . Figure 2C ). 
Parameter
TA B L E 1 3
Effects of the aqueous root bark extract of Byrsocarpus coccineus on differential white blood cell counts of rats infected with E. coli
In the kidney, there was marked congestion, shrunken glomeruli with a wide bowman capsule, tubular necrosis and cellular infiltration in rats infected with E. coli but not treated ( Figure 3B ). The kidney of the infected rats had severe lesions. The rats treated with 200 mg/kg of the extract showed evidence of recovery ( Figure 3C ).
The kidney from the control was normal ( Figure 3A) . Generally, the extract-treated groups had less severe lesions compared with the infected untreated groups.
| D ISCUSS I ON
The use of plants and plant products in the treatment of diseases and other health problems can be attributed to the presence of phytochemical compounds with varying pharmacological and medicinal values. Many of these plants are known to possess both pharmacological and physiological activities. 48, 49 Phytochemical analysis is a very significant aspect of herbal or medicinal plant research, and is used to evaluate the presence of chemical constituents with medicinal value in plants. 49 Flavonoids present in the extract have been reported to possess antioxidant properties. 50 Quercetin, kaempferol and quercitrin are flavonoids commonly present in plants. Tannins have astringent properties, which hasten wound healing and reduce mucus production in inflamed tissue. 51 This activity is due to their ability to precipitate proteins, thereby protecting underlying tissues.
They also inhibit microbial growth and proliferation. 52 Saponins have been shown to possess hypolipidemic, anticancer, expectorant activities. They are used in the treatment of upper respiratory tract inflammation. 31 Volatile oils (essential oils) contribute greatly as an essence in enhancing the aroma of some plant species. 53 They are also used for the management of digestive, respiratory and urinary tract infections. 54 Alkaloids are the largest group of secondary chemical constituents in plants, containing nitrogen-based compounds synthesized from amino acids. They combine with acids to form salts. 55 Therapeutically, alkaloids can serve as central nervous system (CNS) stimulants, anaesthetics, sedatives, analgesics, anti-inflammatory agents, anticancer and muscle relaxants. 56 Acute toxicity studies of extracts of B. coccineus showed that an oral LD 50 > 5000 mg/kg is relatively safe, 57, 58 indicating that the extract could be administered with some degree of safety at lower terized by spasms. 61 The percentage inhibition values for frequency of defecation following treatment with atropine, or increasing doses of extract were 65.0%, 70.01%, 74.96%, and 65.06%, respectively ( Table 3 ).
The ricinoleic acid liberated from castor oil caused irritation of the gastrointestinal tract mucosa, resulting in inflammation, increased gastrointestinal secretion and enhanced motility of the gastrointestinal tract, 62 leading to castor oil-induced diarrhea. 1 The diarrhea also may result from decreased absorption of substances within the intestine. 63 Since the extract was able to inhibit castor oil-induced diarrhea, its antidiarrhea effect may partly be due to its inhibitory effect on gastrointestinal secretion and/or gastrointestinal motility. The reduction in castor oil-induced enteropooling may be due to the ability of the extract to reduce or prevent fluid and electrolyte secretion into the intestine, consequently decreasing gastrointestinal motility similarly to diphenoxylate, a synthetic piperidine opioid structurally related to pethidine, used clinically alone or in combination with atropine for control of non-specific diarrhea in small animals. 5, 9 Therefore, it could be inferred from the results of this study that the decreases in frequency of defecation and distance travelled by the charcoal meal may be due to the inhibition of gastrointestinal motility by the extract.
It is possible that the effect of the extract may be mediated via α2 adrenergic or muscarinic receptor stimulation. to produce enterotoxins that damage the lining of the gastrointestinal mucosa, resulting in diarrhea. 66 The susceptibility of E. coli and S.
pullorum to the extract could be attributed to the presence of tannins and saponins observed to be present in the extract. Generally, tannin is known for its antimicrobial activities in the bark of plants where it protects the plant against bacteria and fungi infections. It also has soothing, anti-inflammatory, antidiuretic and astringent activities. 67 Significant beneficial effects attributed to the use of tannins are seen in wound healing, bleeding, tissue injury and skin regeneration. However, high tannin consumption has been implicated in osteoporosis and anemia in animals and humans due to its effects on calcium and iron absorption. 68 70, 71 Body weight estimation is an index for measuring toxicities in animals. 72 Saganuwan reported a significant number of medicinal plants that could be used in the treatment of diarrhea caused by chemical and infectious agents. 65 Examples of such plants include Anacardium occidentale, Psidium guajava, Sclerocarya birrea, Calotropis procera, Adansonia digitata, Anogeissus schimperi, and
Capsicum ftutescens, among others. 65 The pathogenicity of the E.
coli strain used in this study was confirmed based on the clinical symptoms, mortality and lesions noticed in the infected rats during the experimental period. The present findings agree with the report indicating that E. coli is a commensal bacterium of the intestine that is pathogenic to mammals. 73 The main symptoms observed in E. coli-infected rats, are not exclusive to this species; 74, 75 E. coli strains associated with avian infection usually induce respiratory and septicaemic diseases. 76 The efficacy of the extract in controlling the E. coli infection induced in this study may be due to the presence of some of the phytochemical compounds in the extract such as tannins, phenols, alkaloids and flavonoids, 77 which are known to possess appreciable antibacterial activities. Tannins are known to decrease bacteria cell proliferation by blocking the enzymes of microbial metabolism, producing hydrogen bonds with the carbonyl group in the enzyme (redox reaction). An antimicrobial activity of flavonoids has also been demonstrated. 78 The presence of flavonoids in the extract may thus be responsible for the significant neutrophil counts observed in the present study, since flavonoids are reported to have profound effects on the function of immune and inflammatory cells. 67 Neutrophils play an important role in the defence mechanism of the body by providing the first line of defense against the invading microorganism, being free wandering cells in the body. 79 The eosinophilia observed may be connected with inflammation of the kidney and liver. 80 Eosinophils kill parasites, regulate the hypersensitivity reaction mediated by TgE antibodies and may promote inflammation and tissue damage. 81 The general leucocytosis observed in the E. coli-infected rats may be due to neutrophilia, eosinophilia, basophilia and monocytosis, as proven by differential leucocyte counts. Parasitic infections may be responsible for increased leucocyte counts. 70 Hence the extract may be ef- 
| CON CLUS ION
The B. coccineus extract tested in this study contains flavonoids, tannins, saponins, alkaloids, and phenols, which have potent antimicrobial activities against E. coli and S. pollorum, and as such may be used in the treatment of bacterially and chemically induced diarrhea in rats. The extract of this plant is apparently safe when administered orally. Hence the results of this study confirm folkloric claims that the aqueous root bark extract of B. coccineus can be used to prevent chemical and bacterial diarrhea. The root bark extract has hematinic and plasma expander effects in rats and may therefore be used in treatment of anaemia. It also has cellular immunostimulatory, hepatoprotective and anti-inflammatory effects.
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